BRPI1008887A2 - peptídeos de foxm1 e vacinas contendo os mesmo - Google Patents

peptídeos de foxm1 e vacinas contendo os mesmo

Info

Publication number: BRPI1008887A2
Authority: BR; Brazil
Prior art keywords: same; vaccines containing; foxm1 peptides; foxm1; peptides
Prior art date: 2009-02-18

Application number

BRPI1008887A

Other languages

English (en)

Inventor

Ryuji Ohsawa

Sachiko Yoshimura

Takuya Tsunoda

Tomohisa Watanabe

Original Assignee

Oncotherapy Science Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-02-18

Filing date

2010-02-17

Publication date

2016-03-01

2010-02-17 Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc

2016-03-01 Publication of BRPI1008887A2 publication Critical patent/BRPI1008887A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4242—Transcription factors, e.g. SOX or c-MYC
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BRPI1008887A 2009-02-18 2010-02-17 peptídeos de foxm1 e vacinas contendo os mesmo BRPI1008887A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15340809P	2009-02-18	2009-02-18
PCT/JP2010/001005 WO2010095428A1 (en)	2009-02-18	2010-02-17	Foxm1 peptides and vaccines containing the same

Publications (1)

Publication Number	Publication Date
BRPI1008887A2 true BRPI1008887A2 (pt)	2016-03-01

Family

ID=42633716

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1008887A BRPI1008887A2 (pt)	2009-02-18	2010-02-17	peptídeos de foxm1 e vacinas contendo os mesmo

Country Status (15)

Country	Link
US (1)	US8617562B2 (pt)
EP (1)	EP2408912B1 (pt)
JP (1)	JP5728717B2 (pt)
KR (1)	KR101713586B1 (pt)
CN (1)	CN102405285B (pt)
BR (1)	BRPI1008887A2 (pt)
CA (1)	CA2752560C (pt)
DK (1)	DK2408912T3 (pt)
ES (1)	ES2618896T3 (pt)
IL (1)	IL214435A0 (pt)
MX (1)	MX2011008763A (pt)
RU (1)	RU2560431C2 (pt)
SG (1)	SG173751A1 (pt)
TW (1)	TWI469791B (pt)
WO (1)	WO2010095428A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP4032899A1 (en)	2007-08-20	2022-07-27	Oncotherapy Science, Inc.	Foxm1 peptide and medicinal agent comprising the same
JP6159996B2 (ja) *	2012-03-09	2017-07-12	株式会社富士薬品	ペプチドを含む医薬組成物
GB201410686D0 (en) *	2014-06-16	2014-07-30	Immunocore Ltd & Adaptimmune Ltd	Peptides
HK1251924A1 (en) *	2015-10-08	2019-05-03	Oncotherapy Science, Inc.	Foxm1-derived peptide, and vaccine including same
CN105524159B (zh) *	2015-11-16	2021-04-09	西南交通大学	具有癌细胞选择性杀伤和迁移抑制作用的多肽分子与用途
CN105999227B (zh) *	2016-08-12	2019-08-06	湖南大学	FOXM1蛋白氮端（1-234 aa）的表达及其用途
EP3522909A4 (en)	2016-10-07	2020-07-08	Board of Regents, The University of Texas System	HLA RESTRICTED VGLL1 PEPTIDES AND THEIR USE
CN111787930B (zh) *	2017-10-06	2024-12-20	芝加哥大学	针对癌症特异性抗原对t淋巴细胞的筛选
RS63873B1 (sr) *	2018-04-11	2023-02-28	Enterome S A	Antigenski peptidi za prevenciju i lečenje raka
CN109055327B (zh) *	2018-07-23	2021-04-06	浙江工业大学	醛酮还原酶突变体及其应用
TW202023581A (zh)	2018-08-02	2020-07-01	日商腫瘤療法科學股份有限公司	來自cdca1的胜肽及含有此的疫苗
CN114591400B (zh) *	2022-03-29	2022-10-21	西南交通大学	一组靶向FoxM1-DBD多肽及其应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4722848A (en)	1982-12-08	1988-02-02	Health Research, Incorporated	Method for immunizing animals with synthetically modified vaccinia virus
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
US5679647A (en)	1993-08-26	1997-10-21	The Regents Of The University Of California	Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5804566A (en)	1993-08-26	1998-09-08	The Regents Of The University Of California	Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5739118A (en)	1994-04-01	1998-04-14	Apollon, Inc.	Compositions and methods for delivery of genetic material
US5736524A (en)	1994-11-14	1998-04-07	Merck & Co.,. Inc.	Polynucleotide tuberculosis vaccine
US5922687A (en)	1995-05-04	1999-07-13	Board Of Trustees Of The Leland Stanford Junior University	Intracellular delivery of nucleic acids using pressure
DE69635895D1 (de)	1995-08-03	2006-05-04	Rijksuniversiteit Te Leiden Le	Antigen presentierende bläschen, die von zellen ableiten
US5853719A (en)	1996-04-30	1998-12-29	Duke University	Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
JP2000516090A (ja)	1996-07-26	2000-12-05	スローン―ケッタリングインスティチュートフォーキャンサーリサーチ	遺伝子的免疫化のための方法と試薬
US5861278A (en)	1996-11-01	1999-01-19	Genetics Institute, Inc.	HNF3δ compositions
EP0846761A1 (en)	1996-12-09	1998-06-10	Introgene B.V.	A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof
FR2766205B1 (fr)	1997-07-16	2002-08-30	Inst Nat Sante Rech Med	Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US6747137B1 (en)	1998-02-13	2004-06-08	Genome Therapeutics Corporation	Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
KR100653590B1 (ko)	1998-06-25	2006-12-04	교고 이또	시클로필린 ｂ 유래의 종양 항원 펩티드
US20030235557A1 (en)	1998-09-30	2003-12-25	Corixa Corporation	Compositions and methods for WT1 specific immunotherapy
CA2448881A1 (en)	2001-06-04	2002-12-12	Basf Plant Science Gmbh	Sugar and lipid metabolism regulators in plants ii
US20040142325A1 (en)	2001-09-14	2004-07-22	Liat Mintz	Methods and systems for annotating biomolecular sequences
US20050130899A1 (en)	2001-12-10	2005-06-16	Kyogo Itoh	Tumor antigens
US20040109844A1 (en) *	2002-08-28	2004-06-10	The Board Of Trustees Of The University Of Illinois	Methods of treating age-related defects and diseases
US20060024692A1 (en)	2002-09-30	2006-02-02	Oncotherapy Science, Inc.	Method for diagnosing non-small cell lung cancers
ES2320443T3 (es)	2002-09-30	2009-05-22	Oncotherapy Science, Inc.	Genes y polipeptidos relacionados con canceres pancreaticos humanos.
US20050260639A1 (en)	2002-09-30	2005-11-24	Oncotherapy Science, Inc.	Method for diagnosing pancreatic cancer
TW200413725A (en)	2002-09-30	2004-08-01	Oncotherapy Science Inc	Method for diagnosing non-small cell lung cancers
EP1615658A1 (en)	2003-03-25	2006-01-18	The Board Of Trustees Of The University Of Illinois	Inhibition of tumor cell proliferation by foxm1b inhibitors
EP1668354A2 (en)	2003-09-24	2006-06-14	Oncotherapy Science, Inc.	Method of diagnosing breast cancer
ES2616337T3 (es)	2003-12-12	2017-06-12	Government Of The United States Of America, As Repr. By The Secr. Of The Dept. Of Health And Human Services And His Successors	Un epítopo de linfocito T citotóxico humano y su epítopo agonista del número no variable de secuencias de repetición en tándem de MUC-1
EP1747284A4 (en)	2004-02-06	2009-03-11	Wyeth Corp	DIAGNOSIS AND THERAPEUTICS AGAINST CANCER
CN1977052B (zh)	2004-03-23	2012-09-05	肿瘤疗法科学股份有限公司	与kif11基因相关的双-链分子及载体
EP1730533A1 (en)	2004-03-24	2006-12-13	Oncotherapy Science, Inc.	Adam8 as tumor marker and therapeutic target for non-small cell lung cancer
US7915036B2 (en)	2004-09-13	2011-03-29	The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Compositions comprising T cell receptors and methods of use thereof
JP2006141208A (ja)	2004-11-16	2006-06-08	Univ Of Tokushima	多発性骨髄腫、白血病、悪性リンパ腫、肺癌等の免疫療法剤
JP5109131B2 (ja)	2005-02-10	2012-12-26	オンコセラピー・サイエンス株式会社	膀胱癌を診断する方法
US8053183B2 (en)	2005-07-27	2011-11-08	Oncotherapy Science, Inc.	Method of diagnosing esophageal cancer
EP2298895A1 (en)	2005-07-27	2011-03-23	Oncotherapy Science, Inc.	Method of diagnosing small cell lung cancer
CN101287831B (zh)	2005-09-13	2013-05-15	国立大学法人三重大学	T细胞受体和编码该受体的核酸
EP1806413A1 (en)	2006-01-06	2007-07-11	Oligene GmbH	An in-vitro-method and means for determination of different tumor types and predicting success of surgical procedures in ovarian cancer
US20090311685A1 (en)	2006-04-20	2009-12-17	Oncotherapy Science, Inc	NMU-GHSR1b/NTSR1 oncogenic signaling pathway as a therapeutic target for lung cancer
EP4032899A1 (en)	2007-08-20	2022-07-27	Oncotherapy Science, Inc.	Foxm1 peptide and medicinal agent comprising the same
SG183698A1 (en)	2007-08-20	2012-09-27	Oncotherapy Science Inc	Cdca1 peptide and pharmaceutical agent comprising the same
RU2733985C2 (ru)	2009-03-18	2020-10-09	Онкотерапи Сайенс, Инк.	Пептиды neil3 и включающие их вакцины

2010
- 2010-02-11 TW TW99104319A patent/TWI469791B/zh not_active IP Right Cessation
- 2010-02-17 CA CA2752560A patent/CA2752560C/en not_active Expired - Fee Related
- 2010-02-17 DK DK10743558.8T patent/DK2408912T3/en active
- 2010-02-17 US US13/202,078 patent/US8617562B2/en active Active
- 2010-02-17 EP EP10743558.8A patent/EP2408912B1/en active Active
- 2010-02-17 KR KR1020117021513A patent/KR101713586B1/ko not_active Expired - Fee Related
- 2010-02-17 WO PCT/JP2010/001005 patent/WO2010095428A1/en not_active Ceased
- 2010-02-17 CN CN201080017145.2A patent/CN102405285B/zh active Active
- 2010-02-17 ES ES10743558.8T patent/ES2618896T3/es active Active
- 2010-02-17 JP JP2011535341A patent/JP5728717B2/ja active Active
- 2010-02-17 SG SG2011059441A patent/SG173751A1/en unknown
- 2010-02-17 BR BRPI1008887A patent/BRPI1008887A2/pt not_active IP Right Cessation
- 2010-02-17 RU RU2011138160/10A patent/RU2560431C2/ru not_active IP Right Cessation
- 2010-02-17 MX MX2011008763A patent/MX2011008763A/es active IP Right Grant
2011
- 2011-08-03 IL IL214435A patent/IL214435A0/en unknown

Also Published As

Publication number	Publication date
CA2752560C (en)	2017-01-24
JP2012517799A (ja)	2012-08-09
EP2408912A4 (en)	2013-04-17
MX2011008763A (es)	2011-09-09
AU2010216980A1 (en)	2011-08-25
RU2560431C2 (ru)	2015-08-20
EP2408912A1 (en)	2012-01-25
WO2010095428A1 (en)	2010-08-26
SG173751A1 (en)	2011-09-29
RU2011138160A (ru)	2013-03-27
US20120156231A1 (en)	2012-06-21
TW201032821A (en)	2010-09-16
KR20110117241A (ko)	2011-10-26
ES2618896T3 (es)	2017-06-22
TWI469791B (zh)	2015-01-21
CA2752560A1 (en)	2010-08-26
JP5728717B2 (ja)	2015-06-03
EP2408912B1 (en)	2017-01-18
DK2408912T3 (en)	2017-03-20
US8617562B2 (en)	2013-12-31
CN102405285A (zh)	2012-04-04
CN102405285B (zh)	2015-04-22
IL214435A0 (en)	2011-09-27
KR101713586B1 (ko)	2017-03-08

Publication	Publication Date	Title
BRPI1008887A2 (pt)	2016-03-01	peptídeos de foxm1 e vacinas contendo os mesmo
BRPI0914782A2 (pt)	2016-07-26	peptídeos de epítopos de cdca1 e vacinas contendo os mesmos
DK2552434T3 (da)	2019-06-11	Peptider og anvendelse deraf
IL225607A0 (en)	2013-06-27	Heteroaryls and uses thereof
IL223667B (en)	2018-03-29	S100a4 antibodies and therapeutic uses thereof
IL229926A (en)	2016-11-30	Neil3 peptides and vaccines including the same
BRPI0916940A2 (pt)	2015-11-24	peptídeos de epítopo de melk e vacinas contendo os mesmos.
BRPI1010666A2 (pt)	2017-09-12	peptídeos de cdc45l e vacinas incluindo dos mesmos
BRPI1013938A2 (pt)	2019-09-24	"peptídeos ttk e vacinas incluindo os mesmos"
BRPI0919766A2 (pt)	2017-03-21	peptídeo de epítopo de rab6kifl/kif20a e vacinas contendo o mesmo
BR112013013158A2 (pt)	2017-08-01	peptídeos de tomm34 e vacinas incluindo os mesmos
BRPI1012312A2 (pt)	2017-03-21	peptídeos vangl1 e vacinas incluindo os mesmos
BRPI0923402A2 (pt)	2015-08-04	Peptídeos c10rf59 e vacinas incluindo os mesmos.
BRPI1013384A2 (pt)	2016-03-29	peptídeos c6orf167 e vacinas incluindo os mesmos
ZA201207342B (en)	2013-06-26	Ect2 peptides and vaccines including the same
IL221474A0 (en)	2012-10-31	Hjurp peptides and vaccines including the same
IL220146A0 (en)	2012-07-31	Tmem22 peptides and vaccines including the same
BRPI0922844A2 (pt)	2015-12-29	peptídeos de epítopo de wdrpuh e vacinas contendo os mesmos
IL225553A0 (en)	2013-06-27	54orf18c peptides and vaccines containing them
IL225552A0 (en)	2013-06-27	wdhd1 peptides and vaccines containing them
TH0901004695A (th)	2015-05-29	Rab6kifl/kif20a อิพิโทป เปปไทด์ และ วัคซีนที่ ประกอบด้วยสิ่งเดียวกันนั้น
HK1176365A (en)	2013-07-26	Modified melk peptides and vaccines containing the same
HK1183902A (en)	2014-01-10	Wdhd1 peptides and vaccines including the same
HK1183903A (en)	2014-01-10	C18orf54 peptides and vaccines including the same

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-12-11	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 9A ANUIDADE.
2019-03-26	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-04-02	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2501 DE 11-12-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.
2021-06-01	B350	Update of information on the portal [chapter 15.35 patent gazette]